People in the News

PerkinElmer has appointed CEO and President Robert Friel to the additional job of chairman of its board of directors. The company said that the appointment is part of a leadership succession plan that it adopted in 2007. Friel succeeds Gregory Summe, who did not stand for re-election. Friel started at the company in 1999 as CFO and he was promoted to president and COO in 2007, and he took the CEO spot from Summe last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.